Crocs (CROX) Precio de Acción, Cotización, Noticias e Historial | Benzinga

Crocs Inc (CROX) Precio de Acción, Cotización, Noticias e Historial

CROXNASDAQ

Trade with Public

Trade with Public

$118.09

-1.15-0.96%

Últ. Act.: Oct 2, 4:00 PM

$118.09

-1.15-0.96%

Panorámica generalNoticias Previsión de beneficios Eventos Precios objetivo Finanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Estadísticas Clave

Apertura

$120.33

Cierre

$118.09

Volumen / Prom.

1.01M / 1.05M

Rango diario

$117.67 - $120.33

Rango de 52 semanas

73.21 - 141.28

Capitalización bursátil

$5.66B

Ratio PER

10.58

Rentabilidad por dividendo

-

Exchange

NASDAQ

RSI

45

Interés en corto

13.15%

Días para cubrir

4.79

Noticias Recientes de Crocs, Inc.

Crocs Shares Slide After Report Alleges Company Has a 'Trick for Dodging Taxes'

Shares of Crocs are under selling pressure Wednesday afternoon following an investigative report detailing the footwear manufacturer's offshore tax strategy.

Henry Khederian

Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday

Analysts change outlook & price targets for Crocs, Monolithic Power, Axos Financial, Amazon, Karyopharm, Apple, Guardant Health, Pagaya Tech.

Avi Kapoor

Crocs Shares Sink After Soft Third Quarter Outlook Overshadows Earnings Beat

Crocs shares fell after third-quarter guidance missed estimates, overshadowing second-quarter earnings and revenue beats, despite stronger full-year outlook and a $1.5 billion buyback expansion.

Lekha Gupta

Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Other big gainers in today's session include FuelCell Energy Inc (NASDAQ: FCEL) up 17.6%, BitVentures Limited (NASDAQ: BVC) up 14.1%, and ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) up 10.3% after receiving a positive recommendation for a market authorization in Europe.

Avi Kapoor

Why Is Crocs Stock Falling Thursday?

Crocs (CROX) shares dip despite Q1 earnings beat. Strength in core brand and raised 2026 guidance offset by HEYDUDE weakness. Read more.

Nabaparna Bhattacharya

Finanzas

Trimestral

Anual

Nombre

Ingresos Variación
Bruto Variación
EBITDA Variación
EBIT Variación
Beneficios Variación

Flujos de Caja

Flujo de Caja Operativo (TTM)

762.63M

Flujo de Caja de Inversión (TTM)

-58.01M

Flujo de Caja de Financiación (TTM)

-728.72M

Flujo de Caja Libre (TTM)

704.62M

Gasto de Capital (TTM)

-58.01M

Cambio Neto en Efectivo (TTM)

-24.10M

Tendencia de los analistas

2

abr

2

may

3

jun

2

2

jul

Compra

Mantener

Venta

Venta fuerte

Calificación de analistas

3.6

Compra

Compra fuerte

Compra

Mantener

Venta

Venta fuerte

Métricas de Valoración

Valor Empresarial

$7.18B

Relación P/E (TTM)

10.58

Relación P/E (FWD)

7.86

Relación PEG (TTM)

-

Relación P/S (TTM)

1.51

Relación P/B (TTM)

4.13

Rendimiento de Ganancias % (TTM)

9.45%

Rendimiento de Ganancias % (FWD)

12.72%

EV / EBITDA (TTM)

7.83

Precio / EBITDA (TTM)

6.62

Precio / Flujo de Caja Libre (TTM)

8.68

Valor Contable / Acción

$28.88

Deuda Empresarial

Deuda Total

$1.31B

Deuda a Largo Plazo

$1.31B

Emisión de Deuda a Largo Plazo (TTM)

$575.00M

Reembolso de Deuda a Largo Plazo (TTM)

-$656.00M

Efectivo Total

$170.28M

Deuda a Capital

1.22

Emisión de Deuda (TTM)

-$81.00M

Reembolso de Deuda (TTM)

-$656.00M